STIM
Neuronetics, Inc. Common Stock
Nasdaq · usd
Neuronetics, Inc. Common Stock (STIM) trades at $1.28 (+2.40%) as of 7:30:01 PM EST on Nov 17, 2026, -32.98% over the past month. Market cap is $120.6M, with 9.9 days to cover in short interest.
Stock performance
How Neuronetics, Inc. Common Stock (STIM) stock has performed from one day to one year, with its 52-week range.
- 1D
- +2.40%
- 1W
- -36.32%
- 1M
- -32.98%
- YTD
- -7.25%
- 1Y
- -14.38%
- 52-wk range
- $0.80 – $3.44
Key statistics
Today's trading snapshot for STIM: day range, open, previous close, volume and market cap.
- Day range
- $1.25 – $1.32
- Open
- $1.26
- Prev close
- $1.25
- Volume
- 2.61M
- Market cap
- $120.6M
- Shares out
- 77.73M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Neuronetics, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 0.75
- P/B
- 6.45
- P/FCF
- —
- ROE
- -123.4%
- ROA
- -17.5%
- Debt/Equity
- 3.30
- Div yield
- 0.00%
As of Nov 16, 2026
8-K filings
Material corporate events Neuronetics, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Credit facility drawNov 12, 2026
The Company intends to use a portion of the net proceeds from the Offering to repay a portion of the outstanding term loans under the ... Perceptive Facility. ... A portion of the amounts expected to be repaid ... is attributable to the $10,000,000 of term loans the Company borrowed under tranche 2 of the Perceptive Facility on August 1, 2025.
- Credit facilityNov 10, 2026
On November 5, 2026, the Company entered into Amendment No. 6 to Credit Agreement and Guaranty ... The Perceptive Sixth Amendment amends the Existing Credit Agreement to, among other things, modify certain revenue covenants.
- Quarterly earningsNov 4, 2026
Neuronetics, Inc. (the "Company") issued a press release on November 4, 2026, announcing its financial results for the three and nine months ended September 30, 2026.
- Cfo appointmentAug 17, 2026
On August 12, 2026, the Board appointed Mr. Naor to serve as the Company's principal financial and accounting officer. Mr. Naor's title is now Executive Vice President, Chief Financial Officer, Corporate Secretary, and Treasurer. Mr. Naor's biographical information can be found in the Company's Current Report on Form 8-K filed on July 20, 2026.
- Executive compensation changeJul 20, 2026
On the Separation Date, Mr. Macan will be entitled to his retention bonus in the gross amount of $231,750.00 and the retention award granted to him by the Board of Directors of the Company (the "Board") on December 30, 2025 in the amount of 164,361 Restricted Stock Units, which shall vest on the Separation Date. Mr. Macan will also be entitled to a Separation Payment in the amount of $475,087.50, minus taxes and withholdings payable on regularly scheduled payroll dates for a consecutive period of 12 months.
STIM short interest
How heavily STIM is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 9.9
- Short interest
- 6.66M
- Avg volume
- 673.52K
As of · reported to FINRA twice monthly.
STIM news
The latest news and headlines about Neuronetics, Inc. Common Stock (STIM).
- Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common StocknegativeGlobeNewswire Inc.· Nov 10, 2026
- Neuronetics (STIM) Reports Q3 Loss, Tops Revenue EstimatespositiveZacks Investment Research· Nov 4, 2026
- Beta Bionics, Inc. (BBNX) Reports Q3 Loss, Beats Revenue EstimatesneutralZacks Investment Research· Oct 27, 2026
- Integra LifeSciences (IART) Surpasses Q3 Earnings EstimatesneutralZacks Investment Research· Oct 21, 2026
- Deal Dispatch: Unilever Buys Grüns, Pershing Square Eyes Universal Music Group, Saks Global Reorganization PlanpositiveBenzinga· Apr 10, 2026
Frequently asked questions
What is the Neuronetics, Inc. Common Stock (STIM) stock price today?
Neuronetics, Inc. Common Stock (STIM) is trading at $1.28 (+2.40% on the day) as of 7:30:01 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Neuronetics, Inc. Common Stock?
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
What is the short interest in STIM?
As of Oct 30, 2026, STIM has 6.66M shares short and 9.9 days to cover.
What exchange is STIM listed on?
Neuronetics, Inc. Common Stock (STIM) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Build with AI
Build an analysis of STIM with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a STIM analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.